OUT SMARTING CANCER
SmartCatch was founded with the vision to provide life changing medical devices to the field of oncology research and treatment centers.
CURRENT CHALLENGES IN ONCOLOGY
The current trend in the healthcare sector is a progressive paradigm shift from one size fits all to what the community now refers to as precision medicine. The field of oncology is continuously searching for reliable biomarkers that could provide relevant information for diagnosis, risk stratification, and prognosis of patients.
As cancer biomarkers play a critical role in all stages of cancerous pathology, efforts have focused on the concept of liquid biopsy as a minimally invasive method to extract circulating tumor cells (CTCs).
1 CTC : 1,000,000,000 Normal Cells
Circulating Tumor Cells (CTCs)
physical vectors of cancer aggressiveness and metastatic risks
difficult to capture while maintaining their physiological integrity
carry crucial information such as genetic information, biochemical information, and patient specificity
SmartCatch has developed a series of products in physical CTC capture and isolation.
A compact bench-top product that offers automated direct processing of clinically relevant samples to capture and isolate CTCs.
A portable in-line product that offers integration into existing apheresis machines used in clinics and hospitals to provide long term CTC capture and full compatibility with the S-Station.